In a new study just published this month in the American Journal of Clinical Nutrition, researchers demonstrated that n-acetyl-cysteine significantly decreased plasma homocysteine levels as well as blood pressure.
Homocysteine is an amino acid produced as part of the body’s methylation process and is considered an independent risk factor for cardiovascular disease. This oxidative stress biomarker is associated with an increased risk of many cardiovascular disorders, such as atherosclerosis, stroke, abdominal aortic aneurysm, essential hypertension, and venous thrombosis. The metabolism of homocysteine is highly dependent on in vitamin B12, folate, and vitamin B6. Deficiencies in any of these vitamins may be associated with elevated homocysteine levels.
Lowering homocysteine with B vitamins has been shown through previous research to improve only certain clinical endpoints. However, according to this new study, n-acetyl-cysteine acutely lowers plasma homocysteine as well as blood pressure. Researchers reanalyzed two double-blind, placebo-controlled trials in unmedicated middle-aged men. They evaluated the effect of oral n-acetyl-cysteine given for four weeks at 1.8 g/d on plasma homocyteine, plasma thiol (cysteine), and intracellular glutathione concentrations, as well as on blood pressure.
As a result, four weeks of n-acetyl-cysteine supplementation compared to placebo led to a significant decrease in plasma homocysteine levels. In addition, there was a significant reduction in systolic blood pressure in all the subjects given the n-acetyl-cysteine. A significant reduction in diastolic blood pressure was also seen in the hyperlipidemic group.
The authors conclude that oral intake of n-acetyl-cysteine should be considered for primary or secondary prevention of vascular events with regard to the two independent risk factors of hyperhomocysteinemia and hypertension.
In looking at the whole picture, it is also important to assess laboratory markers such as cardio CRP, homocysteine, fibrinogen, CoQ10, lipoprotein (a), and vitamin D.
Hypertension issues, in many cases, can be solved by simply addressing nutrient deficiencies. It is important to assess mineral status, such as magnesium, calcium, and potassium, as well as toxic metals such as, aluminum, arsenic, cadmium, lead, and mercury, since they can play a significant role with blood pressure regulation.
By Michael Jurgelewicz, DC, DACBN, DCBCN
For Related Resource Information, please listen to our Nutrient Roundtable:
Source: Hildebrandt W., Sauer R., Bonaterra G., Dugi KA., Edler L., Kinscherf R. Oral N-acetycysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status. American Journal of Clinical Nutrition. October 7, 2015.